1. The effect of chronic digitalization on pump function in systolic heart failure.
- Author
-
Hassapoyannes CA, Easterling BM, Chavda K, Chavda KK, Movahed MR, and Welch GW
- Subjects
- Aged, Algorithms, Double-Blind Method, Female, Humans, Male, Middle Aged, Systole drug effects, Cardiac Glycosides therapeutic use, Digitalis adverse effects, Heart Failure drug therapy, Ventricular Function, Left drug effects
- Abstract
Background: Short- and intermediate-term use of cardiac glycosides promotes inotropy and improves the ejection fraction in systolic heart failure., Aim: To determine whether chronic digitalization alters left ventricular function and performance., Methods: Eighty patients with mild-to-moderate systolic heart failure (baseline ejection fraction < or =45%) participated from our institution in a multi-center, chronic, randomized, double-blind study of digitalis vs. placebo. Of the 40 survivors, 38 (20 allocated to the digitalis arm and 18 to the placebo arm) were evaluated at the end of follow-up (mean, 48.4 months). Left ventricular systolic function was assessed by both nuclear ventriculography and echocardiography. The ejection fraction was measured scintigraphically, while the ventricular volumes were computed echocardiographically., Results: The groups did not differ, at baseline or end-of-study, with respect to the ejection fraction and the loading conditions (arterial pressure, ventricular volumes and heart rate) by either intention-to-treat or actual-treatment-received analysis. Over the course of the trial, the digitalis arm exhibited no significant increase in the use of diuretics (18%, P=0.33), in distinction from the placebo group (78%, P=0.004), and a longer stay on study drug among those patients who withdrew from double-blind treatment (28.6 vs. 11.4 months, P=0.01)., Conclusion: Following chronic use of digitalis for mild-to-moderate heart failure, cross-sectional comparison with a control group from the same inception cohort showed no appreciable difference in systolic function or performance. Thus, the suggested clinical benefit cannot be explained by an inotropic effect.
- Published
- 2001
- Full Text
- View/download PDF